Upgrade to SI Premium - Free Trial

BriaCell's Phase 3 breast cancer study clears seventh DSMB review

September 14, 2026 7:30 AM
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL; TSX: BCT) announced that an independent Data Safety Monitoring Board (DSMB) has issued its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA